Inhibitory effect of the novel tyrosine kinase inhibitor DCC-2036 on triple-negative breast cancer stem cells through AXL-KLF5 positive feedback loop
2022 · Cell Death and Disease · 35 citations
https://doi.org/10.1038/s41419-022-05185-x
L
Liyang Yin
Handan College(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
264
Citations
7
h-index
5
i10-index
Liyang Yin is an academic researcher from Handan College. The author has contributed to research in topics: Histone Deacetylase Inhibitors Research & Epigenetics and DNA Methylation & Cancer, Hypoxia, and Metabolism. The author has an h-index of 7, co-authored 18 publications.
Papers by this author
worksEnhancing immunotherapy efficacy in colorectal cancer: targeting the FGR-AKT-SP1-DKK1 axis with DCC-2036 (Rebastinib)
2025 · Cell Death and Disease · 4 citations
https://doi.org/10.1038/s41419-024-07263-8
The Efficacy of Pharmacological Interventions in the Treatment of Major Depressive Disorder and Bipolar Depression With Mixed Features: A Systematic Review
2025 · Bipolar Disorders · 3 citations
https://doi.org/10.1111/bdi.70049
DCC-2036 inhibits osteosarcoma via targeting HCK and the PI3K/AKT-mTORC1 axis to promote autophagy
2025 · World Journal of Surgical Oncology · 1 citations
https://doi.org/10.1186/s12957-025-03778-2
Effects of Intravenous Ketamine on Posttraumatic Stress Disorder ( <scp>PTSD</scp> ): A Systematic Review
2025 · Acta Psychiatrica Scandinavica · 0 citations
https://doi.org/10.1111/acps.70053
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat